MyLife Technologies, a Leiden-based tech startup that was co-founded by Pieter Jan Vos trained as a chemist at Leiden University and the Ecole Superieur de Commerce de Paris (ESCP Europe) in 2012, has developed an alternative to needle injections and oral tablets and capsules. Their innovation, including a patch with microneedles porous, has received an investment of €300,000 from proof-of-concept fund UNIIQ. The investment was announced by Mayor Henri Lenferink during the Dutch Life Sciences conference in Leiden.
Painless drug intake
The new innovation, which comprises a patch and microneedles porous, holds immense significance in the world of medicine. It injects drugs and vaccines into the skin without causing any pain to the patient. The technology can provide significant alternatives to existing dosage forms, including injections and oral medications. The microneedle patches are minimally invasive and painless. It can also allow self-administration by the patient.